PTX 2.44% 4.2¢ prescient therapeutics limited

Ann: December 2018 Appendix 4C - Quarterly, page-3

  1. 711 Posts.
    lightbulb Created with Sketch. 274
    I was worried about that too. It’s also for R&D rather than manufacturing. The upside is they of course get 45% of that back (but not until end of 2019).

    The volumes of trades have been too small for a sell down - it’s just rampant manipulation. The positive out of that is that someone looks like trying to keep the SP down.


    So the question is, is additional funding going to be a CR or partnering arrangement?
    Last edited by megamutts: 31/01/19
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.